Skip to main content
. Author manuscript; available in PMC: 2008 Mar 1.
Published in final edited form as: J Mol Cell Cardiol. 2006 Dec 29;42(3):653–661. doi: 10.1016/j.yjmcc.2006.12.011

Fig 3. Inhibition of GSK-3β inhibits β-AR-stimulated increases in cytosolic cytochrome C levels.

Fig 3

ARVM were pretreated with SB216763 (20 μM; A) for 30 min or infected with adenoviruses expressing catalytically inactive GSK-3β (KM-GSK; B) for 42 h. The cells were then treated with ISO for 6 h. Cytosolic cytochrome C levels were measured using western blot analysis. Actin immunostaining indicates protein loading. *p<0.05 vs. control (CTL/GFP); n=3; #p<0.05 vs. ISO/GFP+ISO; n=3.